Advance Directive

 

An advance directive is a personal statement of how medical care choices should be made and who should make them in the event you are unable to communicate for any reason. A medical power of attorney appoints a specific person (called a health care agent or proxy) to make medical treatment decisions for you, in accordance with your wishes, in the event you are incapacitated. A living will states what kinds of care you want and do not want, and under which circumstances.

Advance directives should be documented and comply with the laws or guidelines in a person's state of residence. Generally, two people witness your signature of the documents. These should be people who are neither designated health care agents nor beneficiaries of the person making the directive. The provisions of your advance directive, such as when to continue or abandon life-support measures, should also be discussed with your health care professional, family members, and your designated health care agent, as well as any other potential decision makers.

It is important to remember that advance directives only come into play if you are incapacitated and cannot make choices and decisions for yourself. As long as you are of sound mind and able to communicate your wishes, you have the right to make any medical choices you desire. You can change your mind at any time, and in fact, you need not comply with your own previously stated advance directives if your wishes or circumstances change. Advance directives are only for others to use and follow in case you can't communicate your wishes yourself.

Latest Cancer News
Vaccine Against HPV-16 Effective for Vulvar Intraepithelial Neoplasia

November 6, 2009 — Researchers from the Netherlands have reported that vaccination with synthetic long-peptides against human papillomavirus (HPV)-16 was effective in treating vulvar intraepithelial neoplasia (VIN). The details of this study were published in the November 5, 2009 issue of the New England Journal of Medicine.

Small HER2-positive Breast Cancers Have a Higher Risk of Recurrence

November 6, 2009 — Researchers from the M. D. Anderson Cancer Center and the University of Milan, Italy, have reported that women with Stage T1a,b, N0M0 HER2-positive breast cancers have a have a high recurrence rate without the administration of adjuvant chemotherapy or Herceptin® (trastuzumab). These data suggest that these women should be treated with Herceptin®-based adjuvant chemotherapy. The details of these two studies appeared in early online publications on November 2, 2009 in the Journal of Clinical Oncology.

Alcohol May Reduce Risk of Thyroid Cancer

November 6, 2009 — Researchers affiliated with the NIH-AARP Diet and Health Study have reported that alcohol intake may reduce the risk of thyroid cancer. The details of this study appeared in the November 4, 2009 issue of the British Journal of Cancer.

Select news items provided by Reuters Health